Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × spartalizumab × Clear all

NCT06364787 2024-04-15

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma

Phase 1 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT02988440 2020-12-19

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms